current
tradit
chines
medicin
tcm
drawn
attent
worldwid
tcm
usual
prepar
formula
uniqu
method
specif
combin
contain
multipl
herb
multipl
compon
formula
work
togeth
achiev
satisfactori
therapeut
efficaci
minim
advers
reaction
howev
synergist
mechan
poorli
understood
must
address
use
holist
approach
pharmacokinet
studi
might
provid
physiolog
relev
clue
target
identif
mechanist
studi
tcm
formula
yupingfeng
ypf
famou
tcm
formula
efficaci
use
health
protect
immun
enhanc
inflammatori
diseas
control
thousand
year
includ
repeat
relaps
respiratori
infect
allerg
rhiniti
chronic
bronchiti
also
play
import
role
sever
acut
respiratori
syndrom
sar
avian
influenza
epidem
outbreak
china
contain
three
uniqu
medicin
plant
figur
astragali
radix
atractylodi
rhizoma
saposhnikovia
radix
ratio
weight
dri
plant
furthermor
numer
pharmacolog
studi
exhibit
varieti
flavonoid
saponin
astragali
radix
sesquiterpenoid
atractylodi
rhizoma
chromon
coumarin
saposhnikovia
radix
show
antiinflammatori
antivir
immunosuppress
activ
well
glycosid
counterpart
may
assum
kind
constitu
could
explain
effect
ypf
formula
analyt
techniqu
base
lcm
report
detect
sever
highabund
compon
counterpart
ypf
biolog
sampl
report
focus
one
kind
compound
singl
herbal
plant
ypf
especi
astragali
radix
saposhnikovia
radix
use
abund
compound
saponin
aglycon
chemic
marker
small
number
report
avail
simultan
analysi
bioactiv
constitu
atractylodi
rhizoma
atractylenolid
low
content
similar
retent
behavior
make
detect
difficult
knowledg
report
integr
pharmacokinet
ingredi
includ
atractylenolid
ii
three
herb
publish
due
high
peak
capac
accur
mass
measur
twodimension
liquid
chromatographi
combin
quadrupol
timeofflight
mass
spectrometri
qtofm
power
techniqu
particularli
separ
complic
herbal
extract
also
use
identifi
unknown
compound
studi
establish
separ
identifi
chemic
compound
ypf
compound
identifi
tent
character
correspond
fragment
pathway
typic
substanc
investig
rapid
simpl
valid
method
use
ultrahighperform
liquid
chromatographi
tripl
quadrupol
mass
spectrometri
uplcqqqm
system
develop
simultan
quantif
astragalosid
calycosin
formononetin
atractylenolid
ii
cimicifugosid
secoglucosylhamaudol
rat
plasma
rel
low
concentr
appli
method
pharmacokinet
studi
ypf
oral
administ
use
area
plasma
curv
zero
infin
weight
factor
make
integr
pharmacokinet
behavior
main
activ
ingredi
firstli
elucid
astragalosid
calycosin
formononetin
atractylenolid
ii
cimicifugosid
secoglucosylhamaudol
standard
purchas
nation
institut
drug
food
control
shanghai
china
seri
number
puriti
refer
standard
accord
hplc
dad
analysi
msgrade
acetonitril
methanol
acet
acid
purchas
merck
darmstadt
germani
deioniz
water
prepar
milliq
system
millipor
corpor
billerica
usa
use
throughout
chemic
analyt
grade
unless
otherwis
note
astragali
radix
root
astragalu
membranaceu
fisch
bge
hsiao
huangqi
atractylodi
rhizoma
rhizom
atractylodi
macrocephala
koidz
baizhu
saposhnikovia
radix
root
saposhnikovia
divar
turez
schischk
fangfeng
dri
herb
purchas
shanghai
pharmaceut
co
ltd
shanghai
china
herb
process
previous
describ
dri
plant
astragali
radix
atractylodi
rhizoma
saposhnikovia
radix
g
weight
mix
doubl
extract
reflux
boil
water
wv
min
thereaft
water
decoct
concentr
gml
crude
drug
decoct
centrifug
min
rpm
stand
supernat
centrifug
min
rpm
filtrat
microvoid
filter
film
directli
inject
lc
system
analysi
primari
standard
stock
solut
astragalosid
mgml
calycosin
mgml
formononetin
mgml
atractylenolid
ii
mgml
cimicifugosid
mgml
mgml
secoglucosylhamaudol
mgml
prepar
dissolv
methanol
stock
solut
appropri
dilut
give
serial
work
standard
solut
spike
aliquot
stock
solut
methanol
qualiti
control
qc
sampl
low
medium
high
concentr
respect
independ
prepar
solut
store
brought
room
temperatur
use
calibr
standard
aliquot
blank
plasma
sampl
work
solut
ad
obtain
final
concentr
ngml
astragalosid
calycosin
cimicifugosid
ngml
atractylenolid
ii
secoglucosylhamaudol
ngml
formononetin
acetonitril
protein
precipit
ad
incur
sampl
methanol
volum
correspond
standard
solut
calibr
curv
sampl
acetonitril
mix
mixtur
vortexextract
min
centrifug
min
rpm
supernat
transfer
new
tube
evapor
gentl
stream
nitrogen
dryness
residu
reconstitut
initi
mobil
phase
vortexmix
min
centrifug
rpm
min
two
dimensionnormalrevers
phase
liquid
chromatographi
combin
quadrupol
timeofflight
mass
spectrometri
use
studi
first
dimens
tsk
gel
column
mm
mm
use
mobil
phase
b
run
mlmin
initi
solvent
b
kept
min
gradient
min
b
min
b
min
b
min
b
min
b
automat
switch
valv
use
collect
effluent
amid
column
everi
min
five
fraction
total
fraction
collect
time
dri
nitrogen
afterward
residu
redissolv
solut
vv
vortexmix
min
centrifug
rpm
min
supernat
inject
second
dimens
second
dimens
water
uplcbeh
column
mm
mm
use
mobil
phase
water
contain
formic
acid
b
flow
rate
mlmin
gradient
min
b
min
b
min
b
min
b
min
b
min
b
detect
identif
carri
rslcnano
liquid
chromatographymaxi
impact
uhrqtofm
bruker
dalton
bremen
germani
thermofish
waltham
usa
equip
esi
sourc
condit
follow
capillari
kv
sampl
cone
v
extract
cone
v
cone
ga
flow
lhr
sourc
temperatur
desolv
ga
flow
lhr
desolv
temperatur
collis
energi
wavelength
rang
nm
lock
mass
mass
rang
set
acquisit
analysi
data
control
masslynx
softwar
water
corpor
milford
usa
peak
detect
peak
align
chromatograph
uplcqqqm
procedur
pharmacokinet
studi
perform
use
acquiti
uplc
water
milford
usa
sciex
selexion
tripl
system
ab
sciex
framingham
usa
equip
heat
electrospray
ioniz
sourc
esi
interfac
separ
achiev
use
water
beh
column
mm
mm
protect
onlin
filter
mobil
phase
flow
rate
mlmin
consist
aqueou
solvent
acid
vv
organ
phase
solvent
b
acetonitril
binari
gradient
elut
perform
separ
consecut
program
follow
isocrat
elut
solvent
b
equilibr
column
follow
linear
gradient
elut
min
b
min
b
min
b
min
b
min
b
min
b
min
b
reequilibr
time
gradient
elut
min
column
autosampl
tray
temperatur
maintain
constantli
respect
inject
volum
electrospray
ioniz
sourc
oper
posit
mode
quantit
perform
schedul
multipl
reaction
monitor
smrm
posit
mode
tandem
mass
spectrometri
msm
typic
instrument
condit
ion
spray
voltag
kv
ion
sourc
ga
psi
ion
sourc
ga
psi
temperatur
curtain
ga
psi
data
acquisit
process
perform
use
analyst
softwar
ab
sciex
corp
framingham
usa
method
fulli
valid
accord
usfda
document
relat
guidelin
respect
specif
linear
precis
accuraci
recoveri
matrix
effect
stabil
select
assess
compar
chromatogram
blank
plasma
sampl
blank
plasma
sampl
spike
work
solut
rat
plasma
sampl
obtain
min
oral
administr
mix
standard
solut
seven
analyt
linear
sensit
linear
assay
test
vivo
compound
total
six
calibr
standard
prepar
blank
rat
plasma
least
six
concentr
respect
obtain
plot
peak
area
analyt
versu
theoret
standard
concentr
x
assess
weigh
leastsquar
linear
regress
use
concentr
x
weight
factor
spssbase
softwar
accuraci
precis
accuraci
precis
intraday
interday
determin
carri
six
replic
sampl
three
qc
level
low
medium
high
within
day
three
consecut
day
matrix
effect
recoveri
matrix
effect
biolog
matrix
rat
plasma
extract
recoveri
evalu
three
qc
level
analyt
six
replic
matrix
effect
assess
via
comparison
peak
respons
analyt
extract
blank
rat
plasma
matrix
obtain
neat
standard
solut
equival
concentr
extract
recoveri
calcul
compar
peak
area
sampl
ad
extract
sampl
ad
extract
stabil
shortterm
longterm
stabil
seven
analyt
rat
plasma
autosampl
vial
h
day
three
cycl
assess
also
carri
six
replic
sampl
three
qc
level
low
medium
high
develop
uplcqqqm
method
appli
pharmacokinet
studi
seven
analyt
rat
plasma
male
healthi
adult
spraguedawley
rat
n
g
bodi
weight
suppli
shanghai
jiao
tong
univers
laboratori
anim
centr
shanghai
china
anim
acclimat
environment
control
breed
room
standard
laboratori
food
water
one
week
prior
experi
rat
fast
h
free
access
water
prior
experi
anim
welfar
experiment
procedur
conform
guidanc
care
use
laboratori
anim
similarli
ethic
regul
sjtu
oral
administr
singl
dose
mgkg
mlkg
astragalosid
calycosin
formononetin
atractylenolid
ii
cimicifugosid
secoglucosylhamaudol
mix
standard
solut
prepar
carboxymethyl
cellulos
sodium
cmcna
blood
sampl
plan
collect
manual
use
heparin
tube
schedul
time
point
min
h
total
blood
volum
collect
session
exceed
male
rat
total
bodi
weight
immedi
centrifug
rpm
minut
plasma
transfer
anoth
via
store
assay
plasma
concentr
seven
analyt
differ
time
point
describ
mean
sd
concentr
versu
time
curv
plot
compartment
model
chosen
calcul
relat
pharmacokinet
paramet
includ
cmax
ngml
tmax
h
clf
lhkg
h
h
calcul
softwar
thermo
fisher
corp
waltham
usa
perform
graphpad
graphpad
softwar
inc
la
jolla
ca
usa
also
use
area
plasma
curv
zero
infin
weight
factor
make
integr
pharmacokinet
curv
plug
variou
valu
follow
equat
integr
concentr
total
analyt
calcul
ct
ca
cb
cc
cd
e
ce
cf
cg
j
respect
repres
analyt
ratio
singl
analyt
total
analyt
ct
selfdefin
integr
concentr
total
analyt
weight
factor
correct
first
step
work
develop
effici
method
enrich
analysi
chemic
constitu
extract
ypf
sinc
constitu
wide
rang
polar
molecular
weight
often
coelut
analog
low
concentr
great
effort
need
solv
encount
difficulti
process
isol
detect
firstli
system
base
two
dimens
orthogon
separ
mechan
develop
aim
enhanc
peak
capac
system
given
complex
chemic
constitu
ypf
need
obtain
best
peak
capac
maxim
meaning
differ
variabl
content
chemic
two
dimension
system
primari
consider
complet
orthogon
separ
mechan
current
hard
achiev
realiti
common
use
system
consist
normal
phase
chromatograph
column
combin
revers
phase
column
addit
major
compon
ypf
decoct
watersolubl
thu
evalu
separ
effici
cn
figur
halo
hilic
hydrophil
interact
liquid
chromatographi
figur
tskgel
amid
figur
column
normal
phase
chromatograph
column
hydrophil
first
dimens
separ
substanc
base
differ
hydrophil
chromatogram
crude
decoct
extract
ypf
shown
figur
almost
peak
could
seen
clearli
obviou
amid
column
best
peak
resolut
sensit
compar
two
pack
materi
amid
column
carbamoyl
instead
aminopropyl
group
bond
silica
gel
bond
phase
significantli
effici
analysi
polysaccharid
glycosid
exist
herb
astragali
radix
atractylodi
rhizoma
saposhnikovia
radix
well
flavonoid
lacton
volatil
oil
etc
fraction
ypf
water
decoct
collect
concentr
separ
first
nplc
system
respect
would
increas
concentr
sampl
sampl
dilut
mobil
phase
first
dimens
would
reduc
detect
limit
second
dimens
order
overcom
shortcom
well
elimin
influenc
solvent
incompat
experi
adopt
method
concentr
sampl
manual
fraction
elut
amid
column
period
time
collect
time
sampl
inject
concentr
dri
nitrogen
dissolv
vv
analysi
second
dimens
chromatographi
analyz
character
fraction
high
resolut
tandem
mass
spectrometri
particularli
qtofm
method
offer
great
mass
accuraci
select
fullscan
mode
consid
henc
uplcqtofm
use
chromatograph
column
second
dimens
establish
isol
five
fraction
repres
chromatogram
figur
second
fraction
min
seen
figur
comparison
chromatogram
crude
decoct
extract
ypf
also
shown
figur
obviou
method
success
enrich
peak
capac
improv
resolut
well
molecular
featur
present
total
five
fraction
method
proven
effici
analysi
chemic
constitu
extract
ypf
larg
number
chemic
constitu
effect
separ
crude
extract
ypf
system
character
use
uplcqtofm
accur
mass
differ
retent
time
abund
extract
howev
compound
detect
overlap
five
fraction
compound
structur
character
base
chromatograph
data
multipl
fragment
structur
inform
compar
standard
refer
previou
literatur
ion
mass
spectra
correspond
fragment
pathway
typic
substanc
shown
figur
ultim
constitu
tabl
tabl
tabl
identifi
tent
character
includ
constitu
isoflavon
flavonoid
saponin
glycosid
astragali
radix
seven
constitu
atractylod
lacton
class
polysaccharid
atractylodi
rhizoma
constitu
chromon
glycosid
saposhnikovia
radix
chemic
constitu
identifi
extract
ypf
seven
major
constitu
chosen
investig
pharmacokinet
behavior
ypf
formula
astragalosid
calycosin
formononetin
astragali
radix
atractylenolid
ii
atractylod
rhizoma
cimicifugosid
secoglucosylhamaudol
saposhnikovia
radix
earli
literatur
pharmacolog
studi
proven
seven
constitu
main
activ
compound
correspond
individu
herb
lead
chang
overal
therapeut
effect
show
remark
antiinflammatori
antivir
immunosuppress
activ
therefor
assum
constitu
could
explain
effect
ypf
formula
howev
challeng
simultan
detect
seven
compound
biolog
sampl
complic
metabol
vivo
wide
differ
level
concentr
propos
uplcqqqm
could
offer
much
lower
limit
detect
make
possibl
analyz
thu
optim
abund
ion
appropri
mass
spectrum
paramet
analysi
directli
inject
standard
solut
compound
use
uplcqqqm
system
list
select
srm
paramet
detect
mode
cone
voltag
cv
collis
energi
ce
retent
time
rt
analyt
present
tabl
fullscan
product
ion
spectra
astragalosid
calycosin
b
formononetin
c
atractylenolid
ii
cimicifugosid
e
f
secoglucosylhamaudol
g
shown
figur
order
make
shorter
analysi
time
good
chromatograph
behavior
appropri
ioniz
use
sever
volatil
addit
formic
acid
acet
acid
ammonium
acet
experi
final
found
addit
acet
acid
aqueou
mobil
phase
provid
better
sensit
peak
symmetri
effici
improv
ioniz
analyt
meanwhil
acetonitril
proven
provid
stabl
practic
column
backpressur
flowrat
mlmin
methanol
consid
initi
percentag
organ
mobil
phase
found
acetonitril
significantli
chang
peak
shape
analyt
percentag
subsequ
sampl
pretreat
procedur
also
investig
protein
precipit
methanol
acetonitril
ethanol
dimethyl
sulfoxid
mix
organ
reagent
employ
methanol
acetonitril
show
satisfi
extract
recoveri
matrix
effect
analyt
within
minimum
number
step
better
yet
acetonitril
permit
uniform
extract
recoveri
lower
background
nois
method
fulli
valid
accord
usfda
document
relat
guidelin
respect
specif
linear
precis
accuraci
recoveri
matrix
effect
stabil
select
six
blank
sampl
rat
plasma
differ
sourc
analyz
repres
smrm
chromatogram
astragalosid
min
calycosin
min
formononetin
min
atractylenolid
ii
min
cimicifugosid
min
min
secoglucosylhamaudol
min
shown
figur
includ
blank
plasma
figur
blank
plasma
spike
analyt
figur
plasma
sampl
normal
rat
min
oral
administr
mixstd
figur
background
nois
low
absenc
endogen
interfer
close
retent
time
analyt
clearli
prove
high
select
method
linear
sensit
lowest
limit
quantif
lloq
calcul
lowest
level
analyt
reliabl
detect
signaltonois
sn
ratio
reproduc
accuraci
summari
regress
equat
coeffici
lloq
seven
analyt
blank
rat
plasma
present
tabl
calibr
curv
exhibit
good
linear
coeffici
determin
within
rang
lloq
sensit
enough
quantit
detect
analyt
pharmacokinet
studi
accuraci
precis
intraday
interday
precis
express
rel
standard
deviat
rsd
exceed
lloq
accuraci
denot
proxim
theoret
concentr
rel
error
true
valu
concentr
observ
valu
concentr
true
valu
concentr
within
lloq
tabl
summar
accuraci
precis
recoveri
matrix
effect
data
seven
analyt
differ
concentr
low
medium
high
rat
plasma
n
intraday
interday
precis
less
term
rsd
accuraci
one
except
cimicifugosid
lowest
concentr
still
accept
valu
indic
overal
reproduc
method
within
bioanalyt
method
valid
accept
criteria
per
fda
ema
guidelin
matrix
effect
recoveri
result
matrix
effect
recoveri
also
summar
tabl
see
extract
recoveri
analyt
matrix
effect
rang
recoveri
calycosin
littl
bit
criteria
result
show
method
consist
precis
reproduc
stabil
analyt
would
consid
stabl
accuraci
bia
within
nomin
concentr
lloq
tabl
show
result
stabil
studi
differ
condit
measur
concentr
seven
analyt
qc
level
within
nomin
valu
indic
stabl
condit
test
seven
analyt
difficult
dissolv
water
carboxymethyl
cellulos
sodium
use
make
suspens
oral
administr
dose
mgkg
mixstandard
determin
previou
pharmacokinet
experi
ypf
decoct
mean
plasma
curv
astragalosid
calycosin
formononetin
atractylenolid
ii
cimicifugosid
secoglucosylhamaudol
present
figur
moreov
integr
pharmacokinet
profil
show
figur
result
correspond
weight
coeffici
seven
analyt
oral
administr
main
pharmacokinet
paramet
list
tabl
tabl
respect
valu
cmax
cimicifugosid
secoglucosylhamaudol
found
higher
compound
one
main
reason
glycosid
counterpart
absorb
intestin
epithelium
effici
aglycon
thu
aglycon
show
biolog
activ
metabol
glycosid
counterpart
vivo
better
fit
twocompart
model
contrast
rel
low
plasma
concentr
atractylenolid
ii
consist
previou
report
show
atracylenolid
ii
poor
intestin
absorpt
rapid
biliari
excret
astragalosid
low
bioavail
characterist
could
difficult
detect
rat
plasma
low
concentr
tmax
h
h
formononetin
absorb
elimin
slowli
isoflavon
calycosin
taken
togeth
result
suggest
constitu
saposhnikovia
radix
demonstr
best
absorpt
pharmacokinet
behavior
among
major
activ
compon
three
medicin
herb
thu
may
play
signific
role
lead
main
chang
overal
therapeut
effect
ypf
howev
discuss
astragali
radix
constitut
import
part
ypf
prescript
chose
seven
main
ingredi
clear
antiinflammatori
activ
ypf
formula
studi
therefor
limit
believ
plasma
drug
concentr
certain
point
regard
combin
quantit
compon
vivo
consid
huge
differ
drug
distribut
rate
elimin
combin
complic
simpl
multipl
sinc
paramet
area
plasma
curv
zero
infin
import
drug
efficaci
pharmacolog
reflect
drug
exposur
directli
meanwhil
measur
intracorpor
drug
exposur
contribut
compon
choos
ratio
singl
overal
weight
factor
ct
selfdefin
integr
plasma
drug
concentr
total
compon
weight
factor
correct
integr
pharmacokinet
curv
show
integr
pharmacokinet
characterist
differ
singl
ingredi
indic
singl
ingredi
pharmacokinet
characterist
fulli
reflect
drug
metabol
overal
medicin
formula
vivo
studi
need
confirm
associ
hope
provid
new
valuabl
method
drug
metabol
research
tradit
chines
medicin
present
studi
develop
platform
separ
identifi
chemic
compound
ypf
total
compound
identifi
tent
character
includ
constitu
isoflavon
flavonoid
saponin
glycosid
astragali
radix
seven
constitu
atractylod
lacton
class
polysaccharid
atractylodi
rhizoma
constitu
chromon
glycosid
saposhnikovia
radix
rapid
simpl
reproduc
uplcqqqm
method
develop
simultan
quantif
seven
major
constitu
astragalosid
calycosin
formononetin
atractylenolid
ii
cimicifugosid
secoglucosylhamaudol
rat
plasma
rel
low
concentr
method
success
valid
appli
preclin
pharmacokinet
studi
addit
also
use
area
plasma
curv
zero
infin
weight
factor
make
integr
pharmacokinet
curv
may
offer
broader
perspect
discov
elucid
pharmacokinet
behavior
clinic
applic
whole
ypf
formula
